{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:55:07Z","timestamp":1790398507267,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0770-y","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T05:03:07Z","timestamp":1565154187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2516-1399","authenticated-orcid":false,"given":"Petronela","family":"Weisov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Cehl\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rostislav","family":"\u0160krabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"\u017dilkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Filip\u010d\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"Kov\u00e1\u010dech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Pr\u010dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u013dubica","family":"Woj\u010diakov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u013dubica","family":"Fialov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Smolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kontsekov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"\u017dilka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Nov\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"issue":"Pt 21","key":"770_CR1","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1242\/jcs.113.21.3737","volume":"113","author":"A Abraha","year":"2000","unstructured":"Abraha A et al (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer\u2019s disease. J Cell Sci 113(Pt 21):3737\u20133745","journal-title":"J Cell Sci"},{"issue":"28","key":"770_CR2","doi-asserted-by":"publisher","first-page":"9677","DOI":"10.1523\/JNEUROSCI.4742-11.2012","volume":"32","author":"O Adolfsson","year":"2012","unstructured":"Adolfsson O et al (2012) An effector-reduced anti-beta-amyloid (Abeta) antibody with unique abeta binding properties promotes neuroprotection and glial engulfment of Abeta. J Neurosci 32(28):9677\u20139689","journal-title":"J Neurosci"},{"issue":"1","key":"770_CR3","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/s41467-017-01575-4","volume":"8","author":"N Ait-Bouziad","year":"2017","unstructured":"Ait-Bouziad N et al (2017) Discovery and characterization of stable and toxic tau\/phospholipid oligomeric complexes. Nat Commun 8(1):1678","journal-title":"Nat Commun"},{"issue":"23","key":"770_CR4","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1016\/j.jmb.2017.09.007","volume":"429","author":"YK Al-Hilaly","year":"2017","unstructured":"Al-Hilaly YK et al (2017) Alzheimer's disease-like paired helical filament assembly from truncated tau protein is independent of disulfide crosslinking. J Mol Biol 429(23):3650\u20133665","journal-title":"J Mol Biol"},{"issue":"6","key":"770_CR5","doi-asserted-by":"publisher","first-page":"E1289","DOI":"10.1073\/pnas.1710329115","volume":"115","author":"RE Bennett","year":"2018","unstructured":"Bennett RE et al (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115(6):E1289\u2013E1298","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"770_CR6","doi-asserted-by":"publisher","first-page":"9034","DOI":"10.1073\/pnas.1530287100","volume":"100","author":"J Berriman","year":"2003","unstructured":"Berriman J et al (2003) Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc Natl Acad Sci U S A 100(15):9034\u20139038","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"770_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/JAD-2011-110977","volume":"28","author":"B Bohrmann","year":"2012","unstructured":"Bohrmann B et al (2012) Gantenerumab: a novel human anti-Abeta antibody demonstrates sustained cerebral amyloid-beta binding and elicits cell-mediated removal of human amyloid-beta. J Alzheimers Dis 28(1):49\u201369","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"770_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E (1995) Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging 16(3):271\u2013278 discussion 278-84","journal-title":"Neurobiol Aging"},{"issue":"8","key":"770_CR9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2015.04.043","volume":"11","author":"S Calafate","year":"2015","unstructured":"Calafate S et al (2015) Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell Rep 11(8):1176\u20131183","journal-title":"Cell Rep"},{"issue":"6\u20137","key":"770_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10571-009-9379-1","volume":"29","author":"M Cente","year":"2009","unstructured":"Cente M, Mandakova S, Filipcik P (2009) Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein. Cell Mol Neurobiol 29(6\u20137):945\u2013949","journal-title":"Cell Mol Neurobiol"},{"key":"770_CR11","doi-asserted-by":"crossref","unstructured":"Cicognola C et al (2018) Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer\u2019s disease. Acta Neuropathol","DOI":"10.1007\/s00401-018-1948-2"},{"issue":"1","key":"770_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nan.12197","volume":"41","author":"F Clavaguera","year":"2015","unstructured":"Clavaguera F et al (2015) Invited review: prion-like transmission and spreading of tau pathology. Neuropathol Appl Neurobiol 41(1):47\u201358","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"49","key":"770_CR13","doi-asserted-by":"publisher","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","volume":"288","author":"EE Congdon","year":"2013","unstructured":"Congdon EE et al (2013) Antibody uptake into neurons occurs primarily via clathrin-dependent Fcgamma receptor endocytosis and is a prerequisite for acute tau protein clearance. J Biol Chem 288(49):35452\u201335465","journal-title":"J Biol Chem"},{"issue":"1","key":"770_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-016-0126-z","volume":"11","author":"EE Congdon","year":"2016","unstructured":"Congdon EE et al (2016) Affinity of tau antibodies for solubilized pathological tau species but not their immunogen or insoluble tau aggregates predicts in vivo and ex vivo efficacy. Mol Neurodegener 11(1):62","journal-title":"Mol Neurodegener"},{"issue":"5","key":"770_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-018-1911-2","volume":"136","author":"JP Courade","year":"2018","unstructured":"Courade JP et al (2018) Epitope determines efficacy of therapeutic anti-tau antibodies in a functional assay with human Alzheimer tau. Acta Neuropathol 136(5):729\u2013745","journal-title":"Acta Neuropathol"},{"issue":"2","key":"770_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pep.2004.01.012","volume":"35","author":"N Csokova","year":"2004","unstructured":"Csokova N et al (2004) Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Protein Expr Purif 35(2):366\u2013372","journal-title":"Protein Expr Purif"},{"issue":"4","key":"770_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon A et al (2012) Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73(4):685\u2013697","journal-title":"Neuron"},{"key":"770_CR18","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.1038\/srep09659","volume":"5","author":"M Derisbourg","year":"2015","unstructured":"Derisbourg M et al (2015) Role of the tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms. Sci Rep 5:9659","journal-title":"Sci Rep"},{"issue":"1","key":"770_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-018-0637-7","volume":"6","author":"S Dujardin","year":"2018","unstructured":"Dujardin S et al (2018) Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun 6(1):132","journal-title":"Acta Neuropathol Commun"},{"issue":"40","key":"770_CR20","doi-asserted-by":"publisher","first-page":"16607","DOI":"10.1021\/ja305206m","volume":"134","author":"S Elbaum-Garfinkle","year":"2012","unstructured":"Elbaum-Garfinkle S, Rhoades E (2012) Identification of an aggregation-prone structure of tau. J Am Chem Soc 134(40):16607\u201316613","journal-title":"J Am Chem Soc"},{"issue":"13","key":"770_CR21","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1016\/j.celrep.2018.03.021","volume":"22","author":"LD Evans","year":"2018","unstructured":"Evans LD et al (2018) Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways. Cell Rep 22(13):3612\u20133624","journal-title":"Cell Rep"},{"issue":"2","key":"770_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1074\/jbc.M114.589309","volume":"290","author":"B Falcon","year":"2015","unstructured":"Falcon B et al (2015) Conformation determines the seeding potencies of native and recombinant tau aggregates. J Biol Chem 290(2):1049\u20131065","journal-title":"J Biol Chem"},{"issue":"5","key":"770_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","volume":"136","author":"B Falcon","year":"2018","unstructured":"Falcon B et al (2018) Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold. Acta Neuropathol 136(5):699\u2013708","journal-title":"Acta Neuropathol"},{"issue":"7","key":"770_CR24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.neurobiolaging.2010.10.015","volume":"33","author":"P Filipcik","year":"2012","unstructured":"Filipcik P et al (2012) First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol Aging 33(7):1448\u20131456","journal-title":"Neurobiol Aging"},{"issue":"7662","key":"770_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AWP et al (2017) Cryo-EM structures of tau filaments from Alzheimer's disease. Nature 547(7662):185\u2013190","journal-title":"Nature"},{"issue":"19","key":"770_CR26","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284(19):12845\u201312852","journal-title":"J Biol Chem"},{"issue":"35","key":"770_CR27","doi-asserted-by":"publisher","first-page":"21652","DOI":"10.1074\/jbc.M115.657924","volume":"290","author":"KE Funk","year":"2015","unstructured":"Funk KE et al (2015) Distinct therapeutic mechanisms of tau antibodies: promoting microglial clearance versus blocking neuronal uptake. J Biol Chem 290(35):21652\u201321662","journal-title":"J Biol Chem"},{"issue":"1","key":"770_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13041-017-0298-7","volume":"10","author":"M Goedert","year":"2017","unstructured":"Goedert M, Spillantini MG (2017) Propagation of tau aggregates. Mol Brain 10(1):18","journal-title":"Mol Brain"},{"issue":"6600","key":"770_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/383550a0","volume":"383","author":"M Goedert","year":"1996","unstructured":"Goedert M et al (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383(6600):550\u2013553","journal-title":"Nature"},{"issue":"1","key":"770_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/alzrt233","volume":"6","author":"TE Golde","year":"2014","unstructured":"Golde TE (2014) Open questions for Alzheimer\u2019s disease immunotherapy. Alzheimers Res Ther 6(1):3","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"770_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13195-018-0337-3","volume":"10","author":"F Goni","year":"2018","unstructured":"Goni F et al (2018) Anti-beta-sheet conformation monoclonal antibody reduces tau and Abeta oligomer pathology in an Alzheimer\u2019s disease model. Alzheimers Res Ther 10(1):10","journal-title":"Alzheimers Res Ther"},{"issue":"15","key":"770_CR32","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1073\/pnas.87.15.5827","volume":"87","author":"SG Greenberg","year":"1990","unstructured":"Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A 87(15):5827\u20135831","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"46","key":"770_CR33","doi-asserted-by":"publisher","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","volume":"288","author":"J Gu","year":"2013","unstructured":"Gu J, Congdon EE, Sigurdsson EM (2013) Two novel tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce tau protein pathology. J Biol Chem 288(46):33081\u201333095","journal-title":"J Biol Chem"},{"issue":"2","key":"770_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VM (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20(2):130\u2013138","journal-title":"Nat Med"},{"issue":"12","key":"770_CR35","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo JL et al (2016) Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice. J Exp Med 213(12):2635\u20132654","journal-title":"J Exp Med"},{"issue":"29","key":"770_CR36","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","volume":"289","author":"BB Holmes","year":"2014","unstructured":"Holmes BB, Diamond MI (2014) Prion-like properties of tau protein: the importance of extracellular tau as a therapeutic target. J Biol Chem 289(29):19855\u201319861","journal-title":"J Biol Chem"},{"issue":"33","key":"770_CR37","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB et al (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A 110(33):E3138\u2013E3147","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"770_CR38","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes BB et al (2014) Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci U S A 111(41):E4376\u2013E4385","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"770_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.brainres.2006.10.085","volume":"1130","author":"M Hrnkova","year":"2007","unstructured":"Hrnkova M et al (2007) Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Brain Res 1130(1):206\u2013213","journal-title":"Brain Res"},{"issue":"3","key":"770_CR40","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M et al (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J Neurosci 33(3):1024\u20131037","journal-title":"J Neurosci"},{"issue":"1","key":"770_CR41","doi-asserted-by":"publisher","first-page":"9008","DOI":"10.1038\/s41598-017-08720-5","volume":"7","author":"E Ihse","year":"2017","unstructured":"Ihse E et al (2017) Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type. Sci Rep 7(1):9008","journal-title":"Sci Rep"},{"issue":"3","key":"770_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1523\/JNEUROSCI.3542-15.2016","volume":"36","author":"SJ Jackson","year":"2016","unstructured":"Jackson SJ et al (2016) Short fibrils constitute the major species of seed-competent tau in the brains of mice transgenic for human P301S tau. J Neurosci 36(3):762\u2013772","journal-title":"J Neurosci"},{"key":"770_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2015.00024","volume":"9","author":"S Jadhav","year":"2015","unstructured":"Jadhav S et al (2015) Truncated tau deregulates synaptic markers in rat model for human tauopathy. Front Cell Neurosci 9:24","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"770_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","volume":"7","author":"S Jadhav","year":"2019","unstructured":"Jadhav S et al (2019) A walk through tau therapeutic strategies. Acta Neuropathol Commun 7(1):22","journal-title":"Acta Neuropathol Commun"},{"issue":"51","key":"770_CR45","doi-asserted-by":"publisher","first-page":"42751","DOI":"10.1074\/jbc.M112.380642","volume":"287","author":"CM Karch","year":"2012","unstructured":"Karch CM, Jeng AT, Goate AM (2012) Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J Biol Chem 287(51):42751\u201342762","journal-title":"J Biol Chem"},{"issue":"7","key":"770_CR46","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","volume":"23","author":"T Katsinelos","year":"2018","unstructured":"Katsinelos T et al (2018) Unconventional secretion mediates the trans-cellular spreading of tau. Cell Rep 23(7):2039\u20132055","journal-title":"Cell Rep"},{"issue":"4","key":"770_CR47","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman SK et al (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92(4):796\u2013812","journal-title":"Neuron"},{"issue":"23","key":"770_CR48","doi-asserted-by":"publisher","first-page":"19440","DOI":"10.1074\/jbc.M112.346072","volume":"287","author":"N Kfoury","year":"2012","unstructured":"Kfoury N et al (2012) Trans-cellular propagation of tau aggregation by fibrillar species. J Biol Chem 287(23):19440\u201319451","journal-title":"J Biol Chem"},{"issue":"4","key":"770_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/alzrt277","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova E et al (2014) Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer\u2019s disease. Alzheimers Res Ther 6(4):45","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"770_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/alzrt278","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova E et al (2014) First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model. Alzheimers Res Ther 6(4):44","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"770_CR51","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2174\/156720510793611556","volume":"7","author":"B Kovacech","year":"2010","unstructured":"Kovacech B, Novak M (2010) Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease. Curr Alzheimer Res 7(8):708\u2013716","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"770_CR52","first-page":"21","volume":"41","author":"C Laurent","year":"2018","unstructured":"Laurent C, Buee L, Blum D (2018) Tau and neuroinflammation: what impact for Alzheimer\u2019s disease and Tauopathies? Biom J 41(1):21\u201333","journal-title":"Biom J"},{"issue":"3","key":"770_CR53","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/JAD-131106","volume":"37","author":"L Levarska","year":"2013","unstructured":"Levarska L et al (2013) Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer's disease. J Alzheimers Dis 37(3):569\u2013577","journal-title":"J Alzheimers Dis"},{"issue":"332","key":"770_CR54","doi-asserted-by":"publisher","first-page":"332ra44","DOI":"10.1126\/scitranslmed.aad3650","volume":"8","author":"CC Liu","year":"2016","unstructured":"Liu CC et al (2016) Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer\u2019s disease. Sci Transl Med 8(332):332ra44","journal-title":"Sci Transl Med"},{"issue":"2","key":"770_CR55","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu L et al (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7(2):e31302","journal-title":"PLoS One"},{"issue":"6","key":"770_CR56","first-page":"541","volume":"36","author":"I Macikova","year":"1992","unstructured":"Macikova I et al (1992) Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and pitman-Moore. Acta Virol 36(6):541\u2013550","journal-title":"Acta Virol"},{"issue":"23","key":"770_CR57","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1002\/1873-3468.13082","volume":"592","author":"A Maiza","year":"2018","unstructured":"Maiza A et al (2018) The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration. FEBS Lett 592(23):3806\u20133818","journal-title":"FEBS Lett"},{"issue":"7","key":"770_CR58","doi-asserted-by":"publisher","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2(7):a006247","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"770_CR59","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1084\/jem.20161731","volume":"214","author":"E Marciniak","year":"2017","unstructured":"Marciniak E et al (2017) Tau deletion promotes brain insulin resistance. J Exp Med 214(8):2257\u20132269","journal-title":"J Exp Med"},{"issue":"28","key":"770_CR60","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1073\/pnas.0401911101","volume":"101","author":"M Margittai","year":"2004","unstructured":"Margittai M, Langen R (2004) Template-assisted filament growth by parallel stacking of tau. Proc Natl Acad Sci U S A 101(28):10278\u201310283","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"770_CR61","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.bcp.2014.01.013","volume":"88","author":"M Medina","year":"2014","unstructured":"Medina M, Avila J (2014) New perspectives on the role of tau in Alzheimer\u2019s disease. Implications for therapy Biochem Pharmacol 88(4):540\u2013547","journal-title":"Implications for therapy Biochem Pharmacol"},{"key":"770_CR62","first-page":"113","volume":"8","author":"M Medina","year":"2014","unstructured":"Medina M, Avila J (2014) The role of extracellular tau in the spreading of neurofibrillary pathology. Front Cell Neurosci 8:113","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"770_CR63","doi-asserted-by":"publisher","first-page":"e76523","DOI":"10.1371\/journal.pone.0076523","volume":"8","author":"JE Meredith Jr","year":"2013","unstructured":"Meredith JE Jr et al (2013) Characterization of novel CSF tau and ptau biomarkers for Alzheimer's disease. PLoS One 8(10):e76523","journal-title":"PLoS One"},{"issue":"24","key":"770_CR64","doi-asserted-by":"publisher","first-page":"14893","DOI":"10.1074\/jbc.M115.652693","volume":"290","author":"H Mirbaha","year":"2015","unstructured":"Mirbaha H et al (2015) Tau trimers are the minimal propagation unit spontaneously internalized to seed intracellular aggregation. J Biol Chem 290(24):14893\u201314903","journal-title":"J Biol Chem"},{"issue":"1","key":"770_CR65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","volume":"5","author":"A Mudher","year":"2017","unstructured":"Mudher A et al (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5(1):99","journal-title":"Acta Neuropathol Commun"},{"issue":"26","key":"770_CR66","doi-asserted-by":"publisher","first-page":"24978","DOI":"10.1074\/jbc.M501565200","volume":"280","author":"MD Mukrasch","year":"2005","unstructured":"Mukrasch MD et al (2005) Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions. J Biol Chem 280(26):24978\u201324986","journal-title":"J Biol Chem"},{"key":"770_CR67","doi-asserted-by":"crossref","unstructured":"Nation DA et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med","DOI":"10.1038\/s41591-018-0297-y"},{"issue":"6","key":"770_CR68","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ajpath.2017.01.022","volume":"187","author":"CK Nobuhara","year":"2017","unstructured":"Nobuhara CK et al (2017) Tau antibody targeting pathological species blocks neuronal uptake and interneuron propagation of tau in vitro. Am J Pathol 187(6):1399\u20131412","journal-title":"Am J Pathol"},{"issue":"1","key":"770_CR69","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/j.1460-2075.1993.tb05665.x","volume":"12","author":"M Novak","year":"1993","unstructured":"Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12(1):365\u2013370","journal-title":"EMBO J"},{"issue":"2","key":"770_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(16)30331-3","volume":"16","author":"P Novak","year":"2017","unstructured":"Novak P et al (2017) Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Neurol 16(2):123\u2013134","journal-title":"Lancet Neurol"},{"key":"770_CR71","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fnins.2018.00798","volume":"12","author":"P Novak","year":"2018","unstructured":"Novak P et al (2018) Ten years of tau-targeted immunotherapy: the path walked and the roads ahead. Front Neurosci 12:798","journal-title":"Front Neurosci"},{"issue":"s1","key":"770_CR72","doi-asserted-by":"publisher","first-page":"S535","DOI":"10.3233\/JAD-179942","volume":"64","author":"P Novak","year":"2018","unstructured":"Novak P et al (2018) Tau conformation as a target for disease-modifying therapy: the role of truncation. J Alzheimers Dis 64(s1):S535\u2013S546","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"770_CR73","first-page":"63","volume":"6","author":"P Novak","year":"2019","unstructured":"Novak P et al (2019) AADvac1, an active immunotherapy for Alzheimer\u2019s disease and non Alzheimer Tauopathies: an overview of preclinical and clinical development. J Prev Alzheimers Dis 6(1):63\u201369","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"770_CR74","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1038\/s41598-018-24904-z","volume":"8","author":"JN Rauch","year":"2018","unstructured":"Rauch JN et al (2018) Tau internalization is regulated by 6-O Sulfation on Heparan sulfate proteoglycans (HSPGs). Sci Rep 8(1):6382","journal-title":"Sci Rep"},{"issue":"1","key":"770_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11481-015-9637-6","volume":"11","author":"SK Schroeder","year":"2016","unstructured":"Schroeder SK et al (2016) Tau-directed immunotherapy: a promising strategy for treating Alzheimer's disease and other Tauopathies. J NeuroImmune Pharmacol 11(1):9\u201325","journal-title":"J NeuroImmune Pharmacol"},{"key":"770_CR76","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.nbd.2018.07.003","volume":"118","author":"MK Schultz Jr","year":"2018","unstructured":"Schultz MK Jr et al (2018) Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice. Neurobiol Dis 118:161\u2013176","journal-title":"Neurobiol Dis"},{"key":"770_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms19040998","volume":"19","author":"A Sebastian-Serrano","year":"2018","unstructured":"Sebastian-Serrano A, de Diego-Garcia L, Diaz-Hernandez M (2018) The Neurotoxic Role of Extracellular Tau Protein. Int J Mol Sci 19:4","journal-title":"Int J Mol Sci"},{"key":"770_CR78","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1038\/ncomms8025","volume":"6","author":"SL Shammas","year":"2015","unstructured":"Shammas SL et al (2015) A mechanistic model of tau amyloid aggregation based on direct observation of oligomers. Nat Commun 6:7025","journal-title":"Nat Commun"},{"issue":"31","key":"770_CR79","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1021\/bi400625v","volume":"52","author":"B Shivu","year":"2013","unstructured":"Shivu B et al (2013) Distinct beta-sheet structure in protein aggregates determined by ATR-FTIR spectroscopy. Biochemistry 52(31):5176\u20135183","journal-title":"Biochemistry"},{"issue":"41","key":"770_CR80","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1021\/bi060964o","volume":"45","author":"N Sibille","year":"2006","unstructured":"Sibille N et al (2006) Structural impact of heparin binding to full-length tau as studied by NMR spectroscopy. Biochemistry 45(41):12560\u201312572","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"770_CR81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000440842","volume":"16","author":"EM Sigurdsson","year":"2016","unstructured":"Sigurdsson EM (2016) Tau immunotherapy. Neurodegener Dis 16(1\u20132):34\u201338","journal-title":"Neurodegener Dis"},{"issue":"1\u20133","key":"770_CR82","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.febslet.2004.04.098","volume":"568","author":"R Skrabana","year":"2004","unstructured":"Skrabana R et al (2004) Folding of Alzheimer\u2019s core PHF subunit revealed by monoclonal antibody 423. FEBS Lett 568(1\u20133):178\u2013182","journal-title":"FEBS Lett"},{"key":"770_CR83","doi-asserted-by":"crossref","unstructured":"Smolek T et al (2018) First-in-rat study of human Alzheimer\u2019s disease tau propagation. Mol Neurobiol","DOI":"10.1007\/s12035-018-1102-0"},{"issue":"27","key":"770_CR84","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1074\/jbc.RA117.000378","volume":"293","author":"BE Stopschinski","year":"2018","unstructured":"Stopschinski BE et al (2018) Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus alpha-synuclein and beta-amyloid aggregates. J Biol Chem 293(27):10826\u201310840","journal-title":"J Biol Chem"},{"issue":"6","key":"770_CR85","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00702-018-1850-z","volume":"125","author":"S Sutovsky","year":"2018","unstructured":"Sutovsky S et al (2018) Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn. J Neural Transm (Vienna) 125(6):965\u2013976","journal-title":"J Neural Transm (Vienna)"},{"key":"770_CR86","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1038\/ncomms9490","volume":"6","author":"S Takeda","year":"2015","unstructured":"Takeda S et al (2015) Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer\u2019s disease brain. Nat Commun 6:8490","journal-title":"Nat Commun"},{"issue":"3","key":"770_CR87","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24716","volume":"80","author":"S Takeda","year":"2016","unstructured":"Takeda S et al (2016) Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients. Ann Neurol 80(3):355\u2013367","journal-title":"Ann Neurol"},{"issue":"1","key":"770_CR88","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-180404","volume":"65","author":"M Vandermeeren","year":"2018","unstructured":"Vandermeeren M et al (2018) Anti-tau monoclonal antibodies derived from soluble and filamentous tau show diverse functional properties in vitro and in vivo. J Alzheimers Dis 65(1):265\u2013281","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"770_CR89","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","volume":"97","author":"M von Bergen","year":"2000","unstructured":"von Bergen M et al (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306) VQIVYK (311)) forming beta structure. Proc Natl Acad Sci U S A 97(10):5129\u20135134","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"770_CR90","doi-asserted-by":"publisher","first-page":"48165","DOI":"10.1074\/jbc.M105196200","volume":"276","author":"M von Bergen","year":"2001","unstructured":"von Bergen M et al (2001) Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 276(51):48165\u201348174","journal-title":"J Biol Chem"},{"issue":"24","key":"770_CR91","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.1073\/pnas.0703676104","volume":"104","author":"YP Wang","year":"2007","unstructured":"Wang YP et al (2007) Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A 104(24):10252\u201310257","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"770_CR92","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1073\/pnas.85.13.4884","volume":"85","author":"CM Wischik","year":"1988","unstructured":"Wischik CM et al (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85(13):4884\u20134888","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"770_CR93","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","volume":"85","author":"CM Wischik","year":"1988","unstructured":"Wischik CM et al (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85(12):4506\u20134510","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"770_CR94","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","volume":"93","author":"CM Wischik","year":"1996","unstructured":"Wischik CM et al (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A 93(20):11213\u201311218","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"770_CR95","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","volume":"288","author":"JW Wu","year":"2013","unstructured":"Wu JW et al (2013) Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem 288(3):1856\u20131870","journal-title":"J Biol Chem"},{"key":"770_CR96","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fnins.2017.00667","volume":"11","author":"K Yamada","year":"2017","unstructured":"Yamada K (2017) Extracellular tau and its potential role in the propagation of tau pathology. Front Neurosci 11:667","journal-title":"Front Neurosci"},{"key":"770_CR97","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-1-4939-6598-4_17","volume":"1523","author":"K Yamada","year":"2017","unstructured":"Yamada K (2017) In vivo microdialysis of brain interstitial fluid for the determination of extracellular tau levels. Methods Mol Biol 1523:285\u2013296","journal-title":"Methods Mol Biol"},{"issue":"37","key":"770_CR98","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1523\/JNEUROSCI.2569-11.2011","volume":"31","author":"K Yamada","year":"2011","unstructured":"Yamada K et al (2011) In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci 31(37):13110\u201313117","journal-title":"J Neurosci"},{"issue":"3","key":"770_CR99","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K et al (2014) Neuronal activity regulates extracellular tau in vivo. J Exp Med 211(3):387\u2013393","journal-title":"J Exp Med"},{"key":"770_CR100","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-015-0052-5","volume":"10","author":"K Yamada","year":"2015","unstructured":"Yamada K et al (2015) Analysis of in vivo turnover of tau in a mouse model of tauopathy. Mol Neurodegener 10:55","journal-title":"Mol Neurodegener"},{"issue":"27","key":"770_CR101","doi-asserted-by":"publisher","first-page":"10841","DOI":"10.1074\/jbc.H118.003970","volume":"293","author":"M Yamada","year":"2018","unstructured":"Yamada M, Hamaguchi T (2018) The sulfation code for propagation of neurodegeneration. J Biol Chem 293(27):10841\u201310842","journal-title":"J Biol Chem"},{"issue":"2","key":"770_CR102","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K et al (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80(2):402\u2013414","journal-title":"Neuron"},{"issue":"5","key":"770_CR103","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bpj.2017.01.024","volume":"112","author":"J Zhao","year":"2017","unstructured":"Zhao J et al (2017) Glycan determinants of heparin-tau interaction. Biophys J 112(5):921\u2013932","journal-title":"Biophys J"},{"key":"770_CR104","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnagi.2018.00027","volume":"10","author":"Y Zhou","year":"2018","unstructured":"Zhou Y et al (2018) Relevance of phosphorylation and truncation of tau to the Etiopathogenesis of Alzheimer's disease. Front Aging Neurosci 10:27","journal-title":"Front Aging Neurosci"},{"key":"770_CR105","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1742-2094-9-47","volume":"9","author":"N Zilka","year":"2012","unstructured":"Zilka N et al (2012) Who fans the flames of Alzheimer\u2019s disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation 9:47","journal-title":"J Neuroinflammation"},{"issue":"4","key":"770_CR106","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1042\/BST20120015","volume":"40","author":"N Zilka","year":"2012","unstructured":"Zilka N et al (2012) The self-perpetuating tau truncation circle. Biochem Soc Trans 40(4):681\u2013686","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"770_CR107","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3233\/JAD-160347","volume":"54","author":"I Zimova","year":"2016","unstructured":"Zimova I et al (2016) Human truncated tau induces mature neurofibrillary pathology in a mouse model of human Tauopathy. J Alzheimers Dis 54(2):831\u2013843","journal-title":"J Alzheimers Dis"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0770-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0770-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0770-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T07:32:31Z","timestamp":1664091151000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0770-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0770-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}